XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (47,733) $ (53,743)
Adjustments to reconcile net income loss to net cash used in operating activities:    
Amortization of debt discount and issuance costs 194 87
Amortization of premium on short-term investments (221) 0
Depreciation expense 487 499
Stock-based compensation expense 4,386 1,428
Non-cash lease expense 579 544
Loss from equity method investment 1,625 0
Loss on impairment of equity investment 675 0
Change in fair value of CVR liability (2,180) 0
Change in fair value of convertible notes (15,890) 6,193
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 276 (94)
Other noncurrent assets 386 (4,503)
Accounts payable (1,043) 2,033
Operating lease liability (1,542) (471)
Accrued expenses and other current liabilities (7,714) 199
Contingent liability 0 55,000
Deferred revenue 0 (25,849)
Net cash used in operating activities (67,715) (18,677)
Cash flows from investing activities:    
Purchases of property and equipment (75) (5)
Maturities of short-term investments 20,000 0
Net cash provided by (used in) investing activities 19,925 (5)
Cash flows from financing activities:    
Proceeds from borrowings under loan and security agreement 7,000 5,500
Payments on borrowings under loan and security agreement 0 (5,200)
Proceeds from issuance of common stock in pre-closing financing 42,000 0
Cash acquired in connection with reverse recapitalization 53,158 0
Payment of reverse recapitalization transaction costs (8,714) 0
Proceeds from exercise of common stock options 1,694 106
Net cash provided by financing activities 95,138 406
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents 47,348 (18,276)
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 31,264 49,540
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period 78,612 31,264
Supplemental disclosure of non-cash operating, investing and financing activities:    
Interest payments on venture debt 856 422
Short Term Investments Acquired In reverse recapitalization 19,905 0
Issuance of CVR at fair value $ 180 $ 0